Latest Breaking News On - Lewish bender - Page 4 : comparemela.com

Intensity Therapeutics to Present at the H C Wainwright 25th Annual Global Investment Conference

/PRNewswire/ Intensity Therapeutics, Inc. (Nasdaq: INTS), a clinical-stage biotechnology company focused on the discovery and development of proprietary,.

United statesMerck sharpe dohmeJonathan nugentLewish benderBristol myers squibbDavid rosenIntensity therapeutics incCompany on twitter intensityincOttawa hospital research instituteNational cancer instituteVaccine branchDevelopment agreementOntario institute of cancer researchIntensity therapeuticsChief executive officerAnnual global investment conference

Intensity Therapeutics Reports Second Quarter Financial Results and Provides Corporate Update

/PRNewswire/ Intensity Therapeutics, Inc. (Nasdaq: INTS), a clinical-stage biotechnology company focused on the discovery and development of proprietary,.

United statesEdna kaplanLewish benderBristol myers squibbMichael millerMerck sharpe dohmeAngel arnaoutOntario institute of cancer researchVaccine branchDevelopment rd expensesNational cancer instituteAmerican society of clinical oncologyDevelopment agreementIntensity therapeutics incCompany on twitter intensityincPrnewswire intensity therapeutics inc

Intensity Therapeutics Reports INT230-6 Can Cause Immune Priming in Historically Quiescent Breast Cancers

/PRNewswire/ Intensity Therapeutics, Inc. ("Intensity"), a clinical-stage biotechnology company focused on the discovery and development of proprietary,.

United statesEdna kaplanBristol myers squibbLewish benderMerck sharpe dohmeMichael millerAngel arnaoutApproval programAmerican society of clinical oncologyVaccine branchDevelopment agreementUniversity of ottawaNational cancer instituteHealth canadaOntario institute for cancer researchCompany on twitter

Intensity Therapeutics INT230-6 Prolongs Survival Alone or in Combination With Ipilimumab in Adult Patients with Relapsed, Refractory, Metastatic Sarcomas

/PRNewswire/ Intensity Therapeutics, Inc. ("Intensity"), a clinical-stage biotechnology company focused on the discovery and development of proprietary,.

United statesChristian frederick meyerMerck sharpe dohmeChristianf meyerMichael millerBristol myers squibbLewish benderEdna kaplanOttawa hospital research instituteOntario institute of cancer researchDrug administrationPrnewswire intensity therapeutics incAmerican society of clinical oncologyCompany on twitterDevelopment agreementRx communications group

Intensity Therapeutics Reports Use of INT230-6 Alone or in Combination with Ipilimumab Shows Evidence of Direct Tumor Necrosis and Promising Overall Survival Results in Adult Subjects with Metastatic

Intensity Therapeutics Reports Use of INT230-6 Alone or in Combination with Ipilimumab Shows Evidence of Direct Tumor Necrosis and Promising Overall Survival Results in Adult Subjects with Metastatic
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesBritish columbiaChristian meyerCommunicationedna kaplanMerck sharpe dohmeLewish benderBristol myers squibbMatthew inghamOttawa hospital research instituteNational cancer instituteCompany on twitterBristol myers squibb companyPrnewswire intensity therapeutics incVaccine branchMerck co incMerck sharp dohme